Más

Panjiva_research_logo

Showing research about Coronavirus

20210302-biden-eo-prods

Biden’s $51 billion supply chain planning exercise

President Biden’s long-awaited Executive Order regarding critical supply chain security will kick off a 100 day review of four sectors to address “production shortages, trade disruptions, natural disasters and potential actions by foreign competitors” covering pharmaceutical ingredients, criti... Read more →

20210225-biome-corp

bioMérieux expands test kit supplies, faces higher freight costs

Medical testing supplier bioMérieux reported Q4’20 revenues which rose by 14.2% year over year, helped by its COVID-19 testing product range. The firm expects a similar rate of growth in 2021. Panjiva’s data shows U.S. seaborne imports linked to the firm rose by 27.3% year over year in Decembe... Read more →

20210224-crocs-corp

Crocs, Birkenstock run ahead as casual leads footwear trade growth

Footwear maker Crocs reported Q4’20 revenue growth of 56.5% year over year and expects a further expansion of 40% to 50% in Q1’21. Crocs’ growth, which has far outstripped the footwear sector, has been driven by its provision of casual footwear during the pandemic though the firm’s CEO, Andrew... Read more →

20210210-masks-macro

Biden’s mask mandate boosts demand as imports slip

The Biden administration’s Executive Order requiring the use of face coverings in domestic and international transportation has been enacted by CDC and Homeland Security and will likely increase demand for face masks and other forms of PPE. U.S. imports of medical supplies needed in the treatm... Read more →

20210201-vaccines-eu

EU lights touch paper for another round of medical protectionism

The European Commission has implemented an export authorization scheme for SARS-COV-2 vaccines covering drugs bought under the Accelerated Purchase Program. That follows a delay in ramping up shipments from AstraZeneca even as the firm’s U.K. plant ran as expected. While the measure is not an ... Read more →

Page 1 of 43